Alcohol in essential tremor and other movement disorders

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2274-2284

  Mostile, Giovanni ^a,b   Jankovic, Joseph ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Alcohol; Alcoholism; Dystonia; Essential tremor; Myoclonus

Indexed keywords

ALCOHOL;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ESSENTIAL TREMOR; HUMAN; MOTOR DYSFUNCTION; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ALCOHOL DRINKING; ALCOHOLISM; ALCOHOLS; ANIMALS; ESSENTIAL TREMOR; HUMANS; MOVEMENT DISORDERS; NEURODEGENERATIVE DISEASES; RISK FACTORS;

EID: 77958604486     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23240     Document Type: Review

References (147)

1. Hernández OH, Vogel-Sprott M, Huchín-Ramirez TC, Aké-Estrada F. Acute dose of alcohol affects cognitive components of reaction time to an omitted stimulus: differences among sensory systems. Psychopharmacology (Berl) 2006; 184: 75-81.
2. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009; 8: 844-856.
3. Koller WC, Hristova A, Brin M. Pharmacologic treatment of essential tremor. Neurology 2000; 54( suppl 4): S30-S38.
4. Hammond ER, Kerr DA. Ethanol responsive tremor in a patient with multiple sclerosis. Arch Neurol 2008; 65: 142-143.
5. Bain PG, Findley LJ, Britton TC, et al. Primary writing tremor. Brain 1995; 118: 1461-1472.
6. Biary N, Koller W. Effect on alcohol on dystonia. Neurology 1985; 35: 239-243.
7. Mubaidin AF. Alcohol with xylocaine for treatment of eyelid dystonia. Eur J Neurol 2000; 7: 213-215.
8. Fahn S, Sjaastad O. Hereditary essential myoclonus in a large Norwegian family. Mov Disord 1991; 6: 237-247.
9. Genton, P, Guerrini R. Antimyoclonic effects of alcohol in progressive myoclonus epilepsy. Neurology 1990; 40: 1412-1416.
10. Lu CS, Chu NS. Alcohol and myoclonus. Neurology 1991; 41: 1165-1166.
11. Jain S, Jain M. Action myoclonus (Lance-Adam syndrome) secondary to strangulation with dramatic response to alcohol. Mov Disord 1991; 6: 183.
12. Quinn NP. Essential myoclonus and myoclonic dystonia. Mov Disord 1996; 11: 119-124.
13. Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: an update. Mov Disord 2009; 24: 479-489.
14. Shapiro AK, Shapiro ES, Young JG, Feinberg TE. Signs, symptoms, and clinical course. In: Shapiro AK, Shapiro ES, Young JG, Feinberg TE, editors. Gilles de la Tourette Syndrome, second ed. New York: Raven Press; 1988. p 127-193.
15. Müller-Vahl KR, Kolbe H, Dengler R. Alcohol withdrawal and Tourette's syndrome. Neurology 1997; 48: 1478-1479.
16. Müller-Vahl KR, Kolbe H, Dengler R. Gilles de la Tourette-syndrom. Einfluß von nikotin, alkohol und marihuana auf die klinische symptomatik. Nervenarzt 1997; 68: 985-989.
17. Demirkiran M, Jankovic J. Paroxysmal dyskinesias: clinical features and classification. Ann Neurol 1995; 38: 571-579.
18. Bruno MK, Lee HY, Auburger GW, et al. Genotype-phenotype correlation of paroxysmal nonkinesigenic dyskinesia. Neurology 2007; 68: 1782-1789.
19. de Vries B, Mamsa H, Stam AH, et al. Episodic ataxia associated with EAAT1 mutation C186S affecting glutamate reuptake [published errata in Arch Neurol 2009;66:497 and Arch Neurol 2009;66(6):772.]. Arch Neurol 2009; 66: 97-101.
20. Griggs RC, Moxley RT, III, Lafrance RA, McQuillen J. Hereditary paroxysmal ataxia: response to acetazolamide. Neurology 1978; 28: 1259-1264.
21. Spacey SD, Materek LA, Szczygielski BI, Bird TD. Two novel CACNA1A gene mutations associated with episodic ataxia type 2 and interictal dystonia. Arch Neurol 2005; 62: 314-316.
22. Charcot JM.Lecture XV. Tremors and choreiform movements. Rhythmical chorea. In: Clinical Lectures on the diseases of the nervous system: delivered at the infirmary of La Salpêtrìere, Vol. III. London: The New Sydenham society; 1889. p 183-187.
23. De Keyser J. Spasmodic torticollis occurring during alcohol withdrawal. Neurology 1993; 43: 623-624.
24. Sandyk R, Gillman MA. Transient Gilles de la Tourette syndrome following alcohol withdrawal. Brit J Add 1985; 80: 213-214.
25. Cardoso F, Vargas AP. Persistent dyskinesia and obsessive-compulsive behavior following alcohol withdrawal. Neurology 1996; 47: 844.
26. Mullin PJ, KershawP W, Bolt JM. Choreoathetotic movement disorder in alcoholism. Br Med J 1970; 4: 278-281.
27. Carlen PL, Lee MA, Jacob M, Livshits O. Parkinsonism provoked by alcoholism. Ann Neurol 1981; 9: 84-86.
28. Neiman J, Borg S, Wahlund LO. Parkinsonism and dyskinesias during ethanol withdrawal. Br J Addict 1988; 83: 437-439.
29. Shandling M, Carlen PL, Lang AE. Parkinsonism in alcohol withdrawal: a follow-up study. Mov Disord 1990; 5: 36-39.
30. Gann H, Feige B, Fasihi S, van Calker D, Voderholzer U, Riemann D. Periodic limb movements during sleep in alcohol dependent patients. Eur Arch Psychiatry Clin Neurosci 2002; 252: 124-129.
31. Neiman J, Lang AE, Fornazzari L, Carlen PL. Movement disorders in alcoholism: a review. Neurology 1990; 40: 741-746.
32. Ferrara J, Jankovic J. Acquired hepatocerebral degeneration. JNeurol 2009; 256: 320-332.
33. Ljubisavljevic M, Kacar A, Milanovic S, Svetel M, Kostic VS. Changes in cortical inhibition during task-specific contractions in primary writing tremor patients. Mov Disord 2006; 21: 855-859.
34. Fleming M, Mihic SJ, Harris RA. Ethanol. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman's the pharmacological basis of therapeutic. New York: McGraw-Hill; 2006. p 591-606.
35. Holford NH. Clinical pharmacokinetics of ethanol. Clin Pharmacokinet 1987; 13: 273-292.
36. Norberg A, Jones AW, Hahn RG, Gabrielsson JL. Role of variability in explaining ethanol pharmacokinetics: research and forensic applications. Clin Pharmacokinet 2003; 42: 1-31.
37. Paton A. Alcohol in the body. Brit Med J 2005; 330: 85-87.
38. Harada S, Agarwal DP, Goedde HW. Aldehyde dehydrogenase deficiency as cause of facial flushing reaction to alcohol in Japanese. Lancet 1981; 2: 982.
39. Chen YC, Peng GS, Wang MF, Tsao TP, Yin SJ. Polymorphism of ethanol-metabolism genes and alcoholism: correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences. Chem Biol Interact 2009; 178: 2-7.
40. Ehlers CL. Variations in ADH and ALDH in Southwest California Indians. Alcohol Res Health 2007; 30: 14-17.
41. Martínez C, García-Martín E, Alonso-Navarro H, et al. Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor. Clin Neuropharmacol 2007; 30: 196-200.
42. Martínez C, García-Martín E, Alonso-Navarro H, et al. Glutathione-S-transferase P1 polymorphism and risk for essential tremor. Eur J Neurol 2008; 15: 234-238.
43. Assunção M, Santos-Marques MJ, de Freitas V, Paula-Barbosa MM, Carvalho F. Modulation of rat cerebellum oxidative status by prolonged red wine consumption. Addict Biol 2008; 13: 337-344.
44. Pan T, Xie W, Le W, Jankovic J. Resveratrol, a polyphenol found in red wine, protects against rotenone-induced apoptosis through autophagy induction. Mov Disord 2009; 24( Suppl 1): S225-S226.
45. Rowland M, Tozer TN. Dose and time dependencies. In: Rowland M, Tozer TN, editors. Clinical pharmacokinetics: concept and application, third ed. Baltimore: Lippincott Williams&Wilkins; 1995. p 406-407.
46. Wilson RH, Newman EJ, Newman HW. Diurnal variation in rate of alcohol metabolism. J Appl Physiol 1956; 8: 556-558.
47. Tsukamoto H, French SW, Reidelberger RD, Largman C. Cyclical pattern of blood alcohol levels during continuous intragastric ethanol infusion in rats. Alcohol Clin Exp Res 1985; 9: 31-37.
48. Harris RA, Trudell JR, Mihic SJ. Ethanol's molecular targets. Sci Signal 2008; 1: re7.
49. Davies DL, Asatryan L, Kuo ST, et al. Effects of ethanol on adenosine 5'-triphosphate-gated purinergic and 5-hydroxytryptamine receptors. Alcohol Clin Exp Res 2006; 30: 349-358.
50. Dildy-Mayfield JE, Mihic SJ, Liu Y, Deitrich RA, Harris RA. Actions of long chain alcohols on GABAA and glutamate receptors: relation to in vivo effects. Br J Pharmacol 1996; 118: 378-384.
51. Mascia MP, Machu TK, Harris RA. Enhancement of homomeric glycine receptor function by long-chain alcohols and anaesthetics. Br J Pharmacol 1996; 119: 1331-1336.
52. Borghese CM, Henderson LA, Bleck V, Trudell JR, Harris RA. Sites of excitatory and inhibitory actions of alcohols on neuronal alpha2beta4 nicotinic acetylcholine receptors [published erratum appears in J Pharmacol Exp Ther 2004;309:439] J Pharmacol Exp Ther 2003; 307: 42-52.
53. Suzdak PD, Schwartz RD, Skolnick P, Paul SM. Ethanol stimulates gamma-aminobutyric acid receptor-mediated chloride transport in rat brain synaptoneurosomes. Proc Natl Acad Sci USA 1986; 83: 4071-4075.
54. Tatebayashi H, Motomura H, Narahashi T. Alcohol modulation of single GABA(A) receptor-channel kinetics. Neuroreport 1998; 9: 1769-1775.
55. Wafford KA, Whiting PJ. Ethanol potentiation of GABAA receptors requires phosphorylation of the alternatively spliced variant of the gamma 2 subunit. FEBS Lett 1992; 313: 113-117.
56. Sundstrom-Poromaa I, Smith DH, Gong QH, et al. Hormonally regulated alpha(4)beta(2)delta GABA(A) receptors are a target for alcohol. Nat Neurosci 2002; 5: 721-722.
57. Wallner M, Hanchar HJ, Olsen RW. Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans. Proc Natl Acad Sci USA 2003; 100: 15218-15223.
58. Mihic SJ, Ye Q, Wick MJ, et al. Sites of alcohol and volatile anaesthetic action on GABA(A) and glycine receptors. Nature 1997; 389: 385-389.
59. Smothers CT, Woodward JJ. Effects of amino acid substitutions in transmembrane domains of the NR1 subunit on the ethanol inhibition of recombinant N-methyl-D-aspartate receptors. Alcohol Clin Exp Res 2006; 30: 523-530.
60. Rudy B, McBain CJ. Kv3 channels: voltage-gated K+ channels designed for high-frequency repetitive firing. Trend Neurosci 2001; 24: 517-526.
61. Espinosa F, McMahon A, Chan E, et al. Alcohol hypersensitivity, increased locomotion, and spontaneous myoclonus in mice lacking the potassium channels Kv3.1 and Kv3.3. J Neurosci 2001; 21: 6657-6665.
62. McMahon A, Fowler SC, Perney TM, Akemann W, Knöpfel T, Joho RH. Allele-dependent changes of olivocerebellar circuit properties in the absence of the voltage-gated potassium channel Kv3.1 and Kv 3.3. Eur J Neurosci 2004; 19: 3317-3327.
63. Weiser M, Vega-Saenz de Miera E, Kentros C, et al. Differential expression of Shaw-related K+ channels in the rat central nervous system. J Neurosci 1994; 14: 949-972.
64. Shahidullah M, Harris T, Germann MW, Covarrubias M. Molecular features of an alcohol binding site in a neuronal potassium channel. Biochemistry 2003; 42: 11243-11252.
65. Aryal P, Dvir H, Choe S, Slesinger PA. A discrete alcohol pocket involved in GIRK channel activation. Nat Neurosci 2009; 12: 988-995.
66. Brodie MS, Scholz A, Weiger TM, Dopico AM. Ethanol interactions with calcium-dependent potassium channels. Alcohol Clin Exp Res 2007; 31: 1625-1632.
67. Liu J, Asuncion-Chin M, Liu P, Dopico AM. CaM kinase II phosphorylation of slo Thr107 regulates activity and ethanol responses of BK channels. Nat Neurosci 2006; 9: 41-49.
68. Lamarre Y. Animal models of physiological, essential and parkinsonian-like tremors. In: Findley LJ, Capildeo R, editors. Movement disorders: tremor. London: Mcmillian; 1984. p 183-194.
69. Llinás R, Yarom Y. Oscillatory properties of guinea-pig inferior olivary neurons and their pharmacological modulation: an in vitro study. J Physiol 1986; 376: 163-182.
70. Llinás R, Paré D. Role of Intrinsic Neuronal Oscillations and Network Ensembles in the Genesis of Normal and Pathological Tremors. In: Findley L, Koller W, editors. Handbook of tremor disorders. New York: Marcel Dekker; 1995. p 7-36.
71. Leznik E, Llinas R. Role of gap junctions in synchronized neuronal oscillations in the inferior olive. J Neurophysiol 2005; 94:2447-2456.
72. Lang EJ, Sugihara I, Llinás R. GABAergic modulation of complex spike activity by the cerebellar nucleoolivary pathway in rat. J Neurophysiol 1996; 76: 255-275.
73. De Zeeuw CI, Simpson JI, Hoogenraad CC, Galjart N, Koekkoek SK, Ruigrok TJ. Microcircuitry and function of the inferior olive. Trends Neurosci 1998; 21: 391-400.
74. Sinton CM, Krosser BI, Walton KD, Llinás RR. The effectiveness of different isomers of octanol as blockers of harmaline-induced tremor. Pflugers Arch 1989; 414: 31-36.
75. Sinclair JG, Lo GF, Harris DP. Ethanol effects on the olivocerebellar system. Can J Physiol Pharmacol 1982; 60: 610-614.
76. Manto M, Laute MA. A possible mechanism for the beneficial effect of ethanol in essential tremor. Eur J Neurol 2008; 15: 697-705.
77. Audinat E, Gähwiler BH, Knöpfel T. Excitatory synaptic potentials in neurons of the deep nuclei in olivo-cerebellar slice cultures. Neuroscience 1992; 49: 903-911.
78. Elble RJ. Animal models of action tremor. Mov Disord 1998; 13( Suppl 3): 35-39.
79. Louis ED, Vonsattel JP, Honig LS, et al. Essential tremor associated with pathologic changes in the cerebellum. Arch Neurol 2006; 63: 1189-1193.
80. Louis ED, Faust PL, Vonsattel JP, et al. Neuropathological changes in essential tremor: 33 cases compared with 21 controls. Brain 2007; 130: 3297-3307.
81. Axelrad JE, Louis ED, Honig LS, et al. Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol 2008; 65: 101-107.
82. Bengtsson F, Svensson P, Hesslow G. Feedback control of Purkinje cell activity by the cerebello-olivary pathway. Eur J Neurosci 2004; 20: 2999-3005.
83. Carta M, Mameli M, Valenzuela CF. Alcohol potently modulates climbing fiber-Purkinje neuron synapses: role of metabotropic glutamate receptors. J Neurosci 2006; 26: 1906-1912.
84. Kralic JE, Criswell HE, Osterman JL, et al. Genetic essential tremor in gamma-aminobutyric acidA receptor alpha1 subunit knockout mice. J Clin Invest 2005; 115: 774-779.
85. Jankovic J, Noebels JL. Genetic mouse models of essential tremor: are they essential? J Clin Invest 2005; 115: 584-586.
86. Deng H, Xie WJ, Le WD, Huang MS, Jankovic J. Genetic analysis of the GABRA1 gene in patients with essential tremor. Neurosci Lett 2006; 401: 16-19.
87. Lou JS, Jankovic J. Essential tremor: clinical correlates in 350 patients. Neurology 1991; 41: 234-238.
88. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain 1994; 117: 805-824.
89. Koller WC, Royse VL. Time course of a single oral dose of propranolol in essential tremor. Neurology 1985; 35: 1494-1498.
90. Elble RJ, Comella C, Fahn S;Tremor Research Group. The essential tremor rating assessment scale (TETRAS). Mov Disord 2008; 23( Suppl 1): S357.
91. Mostile G, Giuffrida JP, Adam OR, Davidson A, Jankovic J. Correlation between Kinesia system assessments and clinical tremor scores in patients with essential tremor. Mov Disord2010 (in press).
92. Rajput AH, Jamieson H, Hirsh S, Quraishi A. Relative efficacy of alcohol and propranolol in action tremor. Can J Neurol Sci 1975; 2: 31-35.
93. Koller WC, Biary N. Effect of alcohol on tremors: comparison with propranolol. Neurology 1984; 34: 221-222.
94. Zeuner KE, Molloy FM, Shoge RO, Goldstein SR, Wesley R, Hallet M. Effect of ethanol on the central oscillator in essential tremor. Mov Disord 2003; 18: 1280-1285.
95. Growdon JH, Shahani BT, Young RR. The effect of alcohol on essential tremor. Neurology 1975; 25: 259-262.
96. Boecker H, Wills AJ, Ceballos-Baumann A, et al. The effect of ethanol on alcohol-responsive essential tremor: a positron emission tomography study. Ann Neurol 1996; 39: 650-658.
97. Bushara KO, Goldstein SR, Grimes GJ, Jr, Burstein AH, Hallet M. Pilot trial of 1-octanol in essential tremor. Neurology 2004; 62: 122-124.
98. Shill HA, Bushara KO, Mari Z, Reich M, Halett M. Open-label dose-escalation study of oral 1-octanol in patients with essential tremor. Neurology 2004; 62: 2320-2322.
99. Klebe S, Stolze H, Grensing K, Volkmann J, Wenzelburger R, Deuschl G. Influence of alcohol on gait in patients with essential tremor. Neurology 2005; 65: 96-101.
100. Singer C, Sanchez-Ramos J, Weiner WJ. Gait abnormality in essential tremor. Mov Disord 1994; 9: 193-196.
101. Stolze H, Petersen G, Raethjen J, Wenzelburger R, Deuschl G. The gait disorder of advanced essential tremor. Brain 2001; 124: 2278-2286.
102. Deuschl G, Wenzelburger R, Löffler K, Raethjen J, Stolze H. Essential tremor and cerebellar dysfunction clinical and kinematic analysis of intention tremor. Brain 2000; 123: 1568-1580.
103. Deuschl G, Bergman H. Pathophysiology of nonparkinsonian tremors. Mov Disord 2002; 17( Suppl 3): S41-S48.
104. Helmchen C, Hagenow A, Miesner J, et al. Eye movement abnormalities in essential tremor may indicate cerebellar dysfunction. Brain 2003; 126: 1319-1332.
105. Markham CH, Diamond SG. The effect of alcohol ingestion on ocular counterrolling. J Vestib Res 2006; 16: 193-199.
106. Diamond SG, Markham CH. Alcohol affects otolith-induced ocular counterrolling: dosage effects. Acta Otolaryngol 2008; 128: 1089-1095.
107. Hess CW, Saunders-Pullman R. Movement disorders and alcohol misuse. Addict Biol 2006; 11: 117-125.
108. Valente EM, Edwards MJ, Mir P, et al. The epsilon-sarcoglycan gene in myoclonic syndromes. Neurology 2005; 64: 737-739.
109. Frucht SJ, Bordelon Y, Houghton WH, Reardan D. A pilot tolerability and efficacy trial of sodium oxybate in ethanol-responsive movement disorders. Mov Disord 2005; 20: 1330-1337.
110. Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: national findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2008.
111. Blazer DG, Wu LT. The epidemiology of at-risk and binge drinking among middle-aged and elderly community adults: National Survey on Drug Use and Health. Am J Psychiatry 2009; 166: 1162-1169.
112. Critchley M. Observations on essential (heredofamilial) tremor. Brain 1949; 72: 113-139.
113. Nasrallah HA, Schroeder D, Petty F. Alcoholism secondary to essential tremor. J Clin Psychiatry 1982; 43: 163-164.
114. Larsson T, Sjogren T. Essential tremor: a clinical and genetic population study. Acta Psychiatr Scand Suppl 1960; 36: 1-176.
115. Rajput AH, Offord KP, Beard CM, Kurland LT. Essential tremor in Rochester, Minnesota: a 45 year study. J Neurol Neurosurg Psychiatry 1984; 47: 466-470.
116. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, Third ed. Washington, DC: The Association; 1980.
117. Schroeder D, Nasrallah HA. High alcoholism rate in patients with essential tremor. Am J Psychiatry 1982; 139: 1471-1473.
118. Solomon JG. Alcoholism and essential tremor in VA patients. Am J Psychiatry 1983; 140: 671.
119. Selzer ML. The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653-1658.
120. Koller WC. Alcoholism in essential tremor. Neurology 1983; 33: 1074-1076.
121. Rautakorpi I, Marttila RJ, Rinne UK. Alcohol consumption of patients with essential tremor. Acta Neurol Scand 1983; 68: 177-179.
122. Louis ED, Jurewicz EC, Applegate LK, Luchsinger JA, Factor-Litvak P, Parides M. Semiquantitative study of current coffee, caffeine, and ethanol intake in essential tremor cases and controls. Mov Disord 2004; 19: 499-504.
123. Jiménez-Jiménez FJ, de Toledo-Heras M, Alonso-Navarro H, et al. Environmental risks factors for essential tremor. Eur Neurol 2007; 58: 106-113.
124. Louis ED, Jurewicz EC, Applegate L, et al. Association between essential tremor and blood lead concentration. Environ Health Perspect 2003; 111: 1707-1711.
125. Salemi G, Aridon P, Calagna G, Monte M, Savettieri G. Population-based case-control study of essential tremor. Ital J Neurol Sci 1998; 19: 301-305.
126. Louis ED, Benito-León J, Bermejo-Pareja F;Neurological Disorders in Central Spain (NEDICES) Study Group. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol 2007; 14: 1138-1146.
127. Dogu O, Louis ED, Tamer L, Unal O, Yilmaz A, Kaleagasi H. Elevated blood lead concentrations in essential tremor: a case-control study in Mersin, Turkey. Environ Health Perspect 2007; 115: 1564-1568.
128. Scarmeas N, Louis ED. Mediterranean diet and essential tremor. A case-control study. Neuroepidemiology 2007; 29: 170-177.
129. Louis ED, Benito-León J, Bermejo-Pareja F. Population-based study of baseline ethanol consumption and risk of incident essential tremor. J Neurol Neurosurg Psychiatry 2009; 80: 494-497.
130. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2000; 58: 242-245.
131. Doheny DO, Brin MF, Morrison CE, et al. Phenotypic features of myoclonus-dystonia in three kindreds. Neurology 2002; 59: 1187-1196.
132. Lang AE, Marsden CD, Obeso JA, Parkes JD. Alcohol and Parkinson disease. Ann Neurol 1982; 12: 254-256.
133. Koller WC. Alcohol and Parkinson Disease. Ann Neurol 1983; 13: 467.
134. Benedetti MD, Bower JH, Maraganore DM, et al. Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study. Neurology 2000; 55: 1350-1358.
135. Wirdefeldt K, Gatz M, Pawitan Y, Pedersen NL. Risk and protective factors for Parkinson's disease: a study in Swedish twins. Ann Neurol 2005; 57: 27-33.
136. Brighina L, Schneider NK, Lesnick TG, et al. α-Synuclein, alcohol use disorders, and Parkinson disease: a case-control study. Parkinsonism Relat Disord 2009; 15: 430-444.
137. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 1993; 17: 192-196.
138. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002; 53: 547-554.
139. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000; 160: 2137-2141.
140. Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997; 62: 51-60.
141. Baker KG, Harding AJ, Halliday GM, Kril JJ, Harper CG. Neuronal loss in functional zones of the cerebellum of chronic alcoholics with and without Wernicke's encephalopathy. Neuroscience 1999; 91: 429-438.
142. Harper C. The neuropathology of alcohol-related brain damage. Alcohol Alcohol 2009; 44: 136-140.
143. Andersen BB. Reduction of Purkinje cell volume in cerebellum of alcoholics. Brain Res 2004; 1007: 10-18.
144. Pentney RJ. Measurements of dendritic pathlengths provide evidence that ethanol-induced lengthening of terminal dendritic segments may result from dendritic regression. Alcohol Alcohol 1995; 30: 87-96.
145. Dlugos CA, Pentney RJ. Morphometric evidence that the total number of synapses on Purkinje neurons of old F344 rats is reduced after long-term ethanol treatment and restored to control levels after recovery. Alcohol Alcohol 1997; 32: 161-172.
146. Dlugos CA. Ethanol-related increases in degenerating bodies in the Purkinje neuron dendrites of aging rats. Brain Res 2008; 1221: 98-107.
147. Geibprasert S, Gallucci M, Krings T. Alcohol-induced changes in the brain as assessed by MRI and CT.Eur Radiol 2010; 20: 1492-1501.